NEWTON: Aflibercept Injection for Previously Treated Macular Edema Associated With Central Retinal Vein Occlusions

NCT01870427 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Macular Edema With Central Retinal Vein Occlusions

Interventions

DRUG: Aflibercept (2.0 mg)

Sponsor

Northern California Retina Vitreous Associates

Collaborators

[object Object]